These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28797192)

  • 1. Profiling extractable and leachable inorganic impurities in ophthalmic drug containers by ICP-MS.
    Solomon P; Nelson J
    Pharm Dev Technol; 2018 Mar; 23(3):247-254. PubMed ID: 28797192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Extractable Elements from Elastomers.
    Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
    PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of leachable impurities in an ophthalmic drug product originating from a polymer additive Irganox 1010 using mass spectroscopy.
    Singh G; Gollapalli R; Blinder A; Patel M
    J Pharm Biomed Anal; 2018 Apr; 152():197-203. PubMed ID: 29414013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug products.
    Menoutis J; Parisi A; Verma N
    J Pharm Biomed Anal; 2018 Apr; 152():12-16. PubMed ID: 29414002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Adduct Impurity of an Active Pharmaceutical Ingredient and a Leachable in an Ophthalmic Drug Product Using LC-QTOF.
    Gollapalli R; Singh G; Blinder A; Brittin J; Sengupta A; Mondal B; Patel M; Pati B; Lee J; Ghode A; Kote M
    J Pharm Sci; 2019 Oct; 108(10):3187-3193. PubMed ID: 31226425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive approach for the determination of extractable and leachable metals in pharmaceutical products by inductively-coupled plasma.
    Zuccarello DJ; Murphy MP; Meyer RF; Winslow PA
    PDA J Pharm Sci Technol; 2009; 63(4):339-52. PubMed ID: 20088247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals.
    Nageswara Rao R; Talluri MV
    J Pharm Biomed Anal; 2007 Jan; 43(1):1-13. PubMed ID: 16891084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clean Chemistry for Elemental Impurities Analysis of Pharmaceuticals in Compliance with USP 232.
    Jin C
    AAPS PharmSciTech; 2016 Oct; 17(5):1141-9. PubMed ID: 26586536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration study of 1,3-butadiene in eye-drop solutions.
    Pistos C; Karampela S; Vardakou I; Papoutsis I; Spiliopoulou C; Athanaselis S
    Drug Chem Toxicol; 2012 Jul; 35(3):293-9. PubMed ID: 22187982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-Scale Assessment of Extractables and Leachables in Single-Use Bags for Biomanufacturing.
    Dorival-García N; Carillo S; Ta C; Roberts D; Comstock K; Lofthouse S; Ciceri E; D'Silva K; Kierans G; Kaisermayer C; Lindeberg A; Bones J
    Anal Chem; 2018 Aug; 90(15):9006-9015. PubMed ID: 29943976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modern approaches to the determination of the content of elemental impurities in the pharmaceutical substances with the use of inductively-coupled plasma mass-spectrometry].
    Bol'shov MA; Seregina IF; Uspenskaya EV; Titorovich OV; Syroeshkin AV; Maksimova TV; Pletneva TV
    Sud Med Ekspert; 2015; 58(6):31-33. PubMed ID: 26856057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICP-MS: Analytical Method for Identification and Detection of Elemental Impurities.
    Mittal M; Kumar K; Anghore D; Rawal RK
    Curr Drug Discov Technol; 2017; 14(2):106-120. PubMed ID: 28003007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D.
    Pluháček T; Ručka M; Maier V
    Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: An Updated Literature Review.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):324-347. PubMed ID: 31843988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On developing a process for conducting extractable-leachable assessment of components used for storage of biopharmaceuticals.
    Wakankar AA; Wang YJ; Canova-Davis E; Ma S; Schmalzing D; Grieco J; Milby T; Reynolds T; Mazzarella K; Hoff E; Gomez S; Martin-Moe S
    J Pharm Sci; 2010 May; 99(5):2209-18. PubMed ID: 20039383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
    Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B
    PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
    Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S
    J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mass spectrometry and related techniques in the analysis of extractable and leachable chemicals.
    Sica VP; Krivos KL; Kiehl DE; Pulliam CJ; Henry ID; Baker TR
    Mass Spectrom Rev; 2020 Mar; 39(1-2):212-226. PubMed ID: 30921495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elemental Impurities in Pharmaceutical Excipients.
    Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
    J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
    Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
    PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.